DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Abergel A, Hezode C, Asselah T. et al.
High efficacy and safety of the combination HCV regimen elbasvir and grazoprevir for 8 weeks in treatment-naive non-severe fibrosis HCVGT1b-infected patients: Final results of the STREAGER study.

Journal of hepatology 2019;
70: E207-E207

Download Bibliographical Data

Search in: